Minimising hypoglycaemia in the real world: the challenge of insulin
- 16 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 64 (5), 978-984
- https://doi.org/10.1007/s00125-020-05354-7
Abstract
Insulin therapy has been a life saver for people with type 1 diabetes and has been an essential tool in the therapy of people with type 2 diabetes, but the risk for hypoglycaemia has been a major hurdle to achieving good glycaemic control for most. Insulin analogues, the availability of novel technologies for the administration of insulin, like insulin pumps, and, in particular, tools to measure glucose levels, evolving from capillary measurements to continuous glucose monitoring, have revolutionised the way in which people living with diabetes use insulin. Novel insulin concepts, like once-weekly or oral insulin administration, will have to demonstrate safety on the side of hypoglycaemia before they will be able to move into the clinic. Graphical abstractThis publication has 45 references indexed in Scilit:
- New forms of insulin and insulin therapies for the treatment of type 2 diabetesThe Lancet Diabetes & Endocrinology, 2015
- Hypoglycaemia in diabetes mellitus: epidemiology and clinical implicationsNature Reviews Endocrinology, 2014
- A Psychoeducational Program to Restore Hypoglycemia Awareness: The DAFNE-HART Pilot StudyDiabetes Care, 2014
- Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 DiabetesDiabetes Care, 2013
- Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource UtilizationValue in Health, 2013
- Type 1 diabetesThe Lancet, 2013
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week ExtensionJournal of Clinical Endocrinology & Metabolism, 2013
- INSULIN DETEMIR IN ROUTINE CLINICAL PRACTICE: A 26-WEEK FOLLOW-UP IN TYPE 1 DIABETIC PATIENTS FROM THE BELGIAN PREDICTIVE COHORTActa Clinica Belgica, 2009
- Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetesDiabetic Medicine, 2006
- Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetesCurrent Medical Research and Opinion, 2005